Jit M - Search Results

1

The impact of alternative delivery strategies for novel tuberculosis vaccines in low-income and middle-income countries: a modelling study.

Clark RA, Mukandavire C, Portnoy A, Weerasuriya CK, Deol A, Scarponi D, Iskauskas A, Bakker R, Quaife M, Malhotra S, Gebreselassie N, Zignol M, Hutubessy RCW, Giersing B, Jit M, Harris RC, Menzies NA, White RG. Clark RA, et al. Among authors: jit m. Lancet Glob Health. 2023 Apr;11(4):e546-e555. doi: 10.1016/S2214-109X(23)00045-1. Lancet Glob Health. 2023. PMID: 36925175 Free PMC article.

2

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models.

Jit M, Demarteau N, Elbasha E, Ginsberg G, Kim J, Praditsitthikorn N, Sinanovic E, Hutubessy R. Jit M, et al. BMC Med. 2011 May 12;9:54. doi: 10.1186/1741-7015-9-54. BMC Med. 2011. PMID: 21569406 Free PMC article.

3

Comparative review of three cost-effectiveness models for rotavirus vaccines in national immunization programs; a generic approach applied to various regions in the world.

Postma MJ, Jit M, Rozenbaum MH, Standaert B, Tu HA, Hutubessy RC. Postma MJ, et al. Among authors: jit m. BMC Med. 2011 Jul 8;9:84. doi: 10.1186/1741-7015-9-84. BMC Med. 2011. PMID: 21740545 Free PMC article. Review.

4

Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries.

Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Deogaonkar R, et al. Among authors: jit m. BMC Public Health. 2012 Oct 16;12:878. doi: 10.1186/1471-2458-12-878. BMC Public Health. 2012. PMID: 23072714 Free PMC article. Review.

5

Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies.

Jit M, Newall AT, Beutels P. Jit M, et al. Hum Vaccin Immunother. 2013 Apr;9(4):834-40. doi: 10.4161/hv.23637. Epub 2013 Jan 28. Hum Vaccin Immunother. 2013. PMID: 23357859 Free PMC article. Review.

6

Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts.

Jit M, Levin C, Brisson M, Levin A, Resch S, Berkhof J, Kim J, Hutubessy R. Jit M, et al. BMC Med. 2013 Jan 30;11:23. doi: 10.1186/1741-7015-11-23. BMC Med. 2013. PMID: 23363734 Free PMC article.

7

Influenza vaccines in low and middle income countries: a systematic review of economic evaluations.

Ott JJ, Klein Breteler J, Tam JS, Hutubessy RC, Jit M, de Boer MR. Ott JJ, et al. Among authors: jit m. Hum Vaccin Immunother. 2013 Jul;9(7):1500-11. doi: 10.4161/hv.24704. Epub 2013 May 31. Hum Vaccin Immunother. 2013. PMID: 23732900 Free PMC article. Review.

8

Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: a systematic review.

Fesenfeld M, Hutubessy R, Jit M. Fesenfeld M, et al. Among authors: jit m. Vaccine. 2013 Aug 20;31(37):3786-804. doi: 10.1016/j.vaccine.2013.06.060. Epub 2013 Jul 3. Vaccine. 2013. PMID: 23830973 Review.

9

Efficacy and effectiveness of seasonal and pandemic A (H1N1) 2009 influenza vaccines in low and middle income countries: a systematic review and meta-analysis.

Breteler JK, Tam JS, Jit M, Ket JC, De Boer MR. Breteler JK, et al. Among authors: jit m. Vaccine. 2013 Oct 25;31(45):5168-77. doi: 10.1016/j.vaccine.2013.08.056. Epub 2013 Sep 5. Vaccine. 2013. PMID: 24012574 Review.

10

Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines.

Newall AT, Jit M, Hutubessy R. Newall AT, et al. Among authors: jit m. Pharmacoeconomics. 2014 Jun;32(6):525-31. doi: 10.1007/s40273-014-0162-x. Pharmacoeconomics. 2014. PMID: 24791735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

417 results

Search Page

Filters